Please login to the form below

Not currently logged in
Email:
Password:

VIR-7831

This page shows the latest VIR-7831 news and features for those working in and with pharma, biotech and healthcare.

Lilly, Vir and GSK’s antibodies reduce viral load by 70% in low-risk COVID-19 patients

Lilly, Vir and GSK’s antibodies reduce viral load by 70% in low-risk COVID-19 patients

Bamlanivimab administered with VIR-7831 also demonstrated a statistically significant reduction in key virologic secondary endpoints compared to placebo. ... This virology data supports our belief that bamlanivimab and VIR-7831 together could be a

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics